Comment on Mayock SP, Saim S, Fleming AB. In Vitro Drug Release After Crushing: Evaluation of Xtampza(®) ER and Other ER Opioid Formulations

Detalles Bibliográficos
Autores principales: Crudele, Nancy, Giordano, Jennifer
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer International Publishing 2018
Materias:
Letter to the Editor
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6061400/
https://www.ncbi.nlm.nih.gov/pubmed/29949103
http://dx.doi.org/10.1007/s40261-018-0663-z
_version_ 1783342217153216512
author Crudele, Nancy
Giordano, Jennifer
author_facet Crudele, Nancy
Giordano, Jennifer
author_sort Crudele, Nancy
collection PubMed
description
format Online
Article
Text
id pubmed-6061400
institution National Center for Biotechnology Information
language English
publishDate 2018
publisher Springer International Publishing
record_format MEDLINE/PubMed
spelling pubmed-60614002018-08-09 Comment on Mayock SP, Saim S, Fleming AB. In Vitro Drug Release After Crushing: Evaluation of Xtampza(®) ER and Other ER Opioid Formulations Crudele, Nancy Giordano, Jennifer Clin Drug Investig Letter to the Editor Springer International Publishing 2018-06-12 2018 /pmc/articles/PMC6061400/ /pubmed/29949103 http://dx.doi.org/10.1007/s40261-018-0663-z Text en © The Author(s) 2018 Open AccessThis article is distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/), which permits any noncommercial use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made.
spellingShingle Letter to the Editor
Crudele, Nancy
Giordano, Jennifer
Comment on Mayock SP, Saim S, Fleming AB. In Vitro Drug Release After Crushing: Evaluation of Xtampza(®) ER and Other ER Opioid Formulations
title Comment on Mayock SP, Saim S, Fleming AB. In Vitro Drug Release After Crushing: Evaluation of Xtampza(®) ER and Other ER Opioid Formulations
title_full Comment on Mayock SP, Saim S, Fleming AB. In Vitro Drug Release After Crushing: Evaluation of Xtampza(®) ER and Other ER Opioid Formulations
title_fullStr Comment on Mayock SP, Saim S, Fleming AB. In Vitro Drug Release After Crushing: Evaluation of Xtampza(®) ER and Other ER Opioid Formulations
title_full_unstemmed Comment on Mayock SP, Saim S, Fleming AB. In Vitro Drug Release After Crushing: Evaluation of Xtampza(®) ER and Other ER Opioid Formulations
title_short Comment on Mayock SP, Saim S, Fleming AB. In Vitro Drug Release After Crushing: Evaluation of Xtampza(®) ER and Other ER Opioid Formulations
title_sort comment on mayock sp, saim s, fleming ab. in vitro drug release after crushing: evaluation of xtampza(®) er and other er opioid formulations
topic Letter to the Editor
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6061400/
https://www.ncbi.nlm.nih.gov/pubmed/29949103
http://dx.doi.org/10.1007/s40261-018-0663-z
work_keys_str_mv AT crudelenancy commentonmayockspsaimsflemingabinvitrodrugreleaseaftercrushingevaluationofxtampzaerandothereropioidformulations
AT giordanojennifer commentonmayockspsaimsflemingabinvitrodrugreleaseaftercrushingevaluationofxtampzaerandothereropioidformulations

Ejemplares similares